Analystreport

Axsome Therapeutics Inc (NASDAQ: AXSM) had its price target raised by analysts at Guggenheim from $65.00 to $48.00.

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com